Clonidine suppression testing in essential hypertension

D. S. Goldstein, P. D. Levinson, R. Zimlichman, A. Pitterman, R. Stull, H. R. Keiser

Research output: Contribution to journalArticlepeer-review

77 Scopus citations

Abstract

To assess the contribution of sympathetic outflow to blood pressure in patients with essential hypertension, we measured blood pressure and plasma norepinephrine response to clonidine, an antihypertensive agent that decreases central sympathetic outflow, in 44 patients and in 41 normotensive control subjects of similar age. Among the hypertensive patients, the resting level of plasma norepinephrine was significantly related to the decrease in mean arterial pressure 3 hours after a single oral dose of clonidine, 300 μg (r = 0.62, p<0.001). The magnitude of the depressor response in the patients also was correlated significantly with the decrease in plasma norepinephrine after clonidine (r = 0.60, p<0.001). These results suggest that increased sympathetic outflow plays a pathophysiologic role in some patients with essential hypertension.

Original languageEnglish
Pages (from-to)42-48
Number of pages7
JournalAnnals of Internal Medicine
Volume102
Issue number1
DOIs
StatePublished - 1985
Externally publishedYes

Fingerprint

Dive into the research topics of 'Clonidine suppression testing in essential hypertension'. Together they form a unique fingerprint.

Cite this